In these tumors, a histological barrier formed by the interaction of cancer-associated fibroblasts (CAFs) and SPP1+ macrophages decreases immunotherapy efficacy by limiting cytotoxic immune cell infiltration into malignant regions [74, 75]. Here, SPP1 is linked to cancer.